In a groundbreaking advance at the forefront of asymmetric catalysis and chiral molecule synthesis, a research collaboration spearheaded by Guoqiang Yang, Wanbin Zhang, and Jianming Zhang at Shanghai Jiao Tong University has unveiled a novel bimetallic copper-catalyzed strategy that deftly constructs chiral N-unprotected cyclic imidate esters with exceptional stereocontrol. Published recently in CCS Chemistry, this landmark work showcases a dual copper catalytic system that operates through a transient binuclear mechanism, merging the classical propargyl substitution reaction with the Pinner reaction in a seamless tandem process. The result is a highly efficient and precise synthetic route to chiral cyclic imines, monumental molecules with profound implications in medicinal chemistry and catalyst design.
At the heart of this innovation lies the asymmetric bimetallic synergistic copper-catalyzed propargyl substitution (CuAPS), an elegant transformation where the activation of both the propargyl electrophile and α-cyano ester nucleophile is finely orchestrated. This is mediated by a chiral Cu(I)–BOX complex catalyst, which not only recognizes the subtle electronic landscapes of both substrates but also transiently assembles into a binuclear complex of quasi-C₂ symmetry. This dynamic entity, combining a Cu-propynyl intermediate on one side and a stabilized deprotonated α-cyano ester on the other, facilitates an exquisitely stereoselective carbon–carbon bond formation. The conformational locking enabled by H···π stacking interactions underpins the high enantio- and diastereoselectivity achieved, culminating in yields of cyclic imidates with enantioselectivities as high as 94%.
This breakthrough addresses a longstanding challenge in asymmetric synthesis: the comprehensive activation and stereocontrol over both partners in propargyl substitution reactions. Historically, the understanding of catalytic activation modes has been fragmented, limiting the scope and efficiency of constructing chiral propargyl skeletons. Moreover, chiral cyclic imides—particularly those accessed as N-unprotected variants—have remained elusive targets due to synthetic limitations. The approach presented here revolutionizes this field by harnessing a transiently formed, dual-copper catalytic system that effectively lowers activation barriers and unlocks previously inaccessible chemical space.
One of the most striking facets of this method is its broad substrate scope and robustness under mild reaction conditions. The system tolerates diverse propargyl carbonates and α-cyano esters bearing a variety of functional groups, enabling the rapid assembly of structurally diverse chiral cyclic imidates. This versatility not only expands the utility of chiral imidates but also opens myriad avenues for late-stage functionalization and derivatization, positioning these scaffolds as versatile building blocks in synthetic and medicinal chemistry.
The potential of the synthesized cyclic imine esters extends well beyond their immediate formation. Their rich functional group profile, including reactive N–H and alkynyl groups, permits facile post-synthetic modification. Using strategies such as N-alkylation and the Sonogashira cross-coupling reaction, researchers can swiftly access a library of chiral imidate derivatives with tailored properties. This modularity is particularly valuable in drug discovery, where rapid generation of analogues is critical for structure-activity relationship studies and optimization of pharmacological profiles.
In a compelling demonstration of the biomedical promise embedded in these new compounds, several derivatives exhibited remarkable antiviral activity against the feline calicivirus (FCV) infection model. The antiviral efficacy surpassed that of nitrozonide, a benchmark positive control drug, highlighting these chiral imidates not only as chemical curiosities but also as potential therapeutic leads. This intersection of synthetic innovation and biological relevance underscores the translational impact of the research and fuels optimism for future drug development endeavors centered on these novel scaffolds.
The mechanistic insights gained through this work are equally transformative. The transient binuclear copper complex and its quasi-C₂ symmetric nature elucidate how the cooperative interplay between two distinct copper catalytic centers can be tactically exploited to direct stereochemical outcomes with precision. Such mechanistic clarity paves the way for the rational design of next-generation bimetallic catalysts tailored for other challenging asymmetric transformations, signaling a paradigm shift in catalyst development.
From a practical perspective, the catalytic efficiency demonstrated—manifested in high substrate-to-catalyst ratios (S/C up to 2000)—and mild reaction milieu suggest scalability and potential industrial applicability. The synthetic accessibility and operational simplicity may transform how chiral cyclic imidates are produced at scale, benefiting sectors ranging from pharmaceutical synthesis to agrochemicals and materials science.
This research also embodies the spirit of international collaboration and support, having been facilitated by foundational grants provided by the Fundamental Research Funds for the Central Universities and Shanghai Jiao Tong University’s Research Start-up Fund. The choice to publish open access in CCS Chemistry, a premier platform established by the Chinese Chemical Society to disseminate cutting-edge chemical research globally, ensures that these scientific advancements are readily accessible to the worldwide community, accelerating innovation.
The Chinese Chemical Society, established in 1932 and now comprising over 120,000 members worldwide, continues to foster the growth and development of chemistry in China and beyond. Its flagship publication CCS Chemistry serves as a beacon for seminal discoveries like this, bridging frontiers in fundamental chemistry and its applications with open sharing of knowledge.
Ultimately, this study represents a hallmark achievement in asymmetric catalysis, with the dual copper-catalyzed tandem reaction epitomizing synergy at the molecular level to unlock new chemical transformations. The confluence of mechanistic insight, synthetic scope, catalytic performance, and biological activity exemplifies the multidisciplinary impact of modern chemistry, affirming its pivotal role in addressing both scientific and societal challenges.
As researchers delve deeper into the subtleties of bimetallic synergy and continue optimizing related catalytic systems, the horizon promises even more unprecedented reactions, new classes of chiral molecules, and potential breakthroughs in drug discovery. The chiral N-unprotected cyclic imidates synthesized through this elegant methodology are poised to become indispensable tools, laying the foundation for future innovations in chemical synthesis and therapeutic development.
Subject of Research: Not applicable
Article Title: Bimetallic Copper-Catalyzed Asymmetric Propargylic Substitution: Synthesis of Chiral N-Unprotected Imidates, Mechanistic Study, and Antiviral Activity
News Publication Date: 5-Mar-2026
Web References:
– CCS Chemistry Journal: https://www.chinesechemsoc.org/journal/ccschem
– Chinese Chemical Society: https://www.chinesechemsoc.org/
References:
DOI: 10.31635/ccschem.026.202507061
Image Credits: CCS Chemistry
Keywords
Catalysis, Asymmetric synthesis, Copper catalysis, Propargyl substitution, Chiral imidates, Binuclear catalysis, Tandem reaction, Enantioselectivity, Pinner reaction, Antiviral compounds, Medicinal chemistry, Chiral ligand design
